Measuring Medication Safety.qxd page 53
author: gbon
Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
Millennium | Media | Press Releases | 2002 | 2002-11-11 2003 2002 Millennium Announces Initiation of Phase III Clinical Trial of Integrilin ® (eptifibatide) Injection in Heart Attack Patients Cambridge, Mass., November 11, 2002 - Millennium Pharmaceuticals, Inc.Eptifibatide Monotherapy in Acute Myocardial...
Millennium | Research and Development | Cardiovascular | Development Candidates | INTEGRILIN INTEGRILIN ® Disease Overview Development Candidates Discovery Research Alliances Team DEVELOPMENT CANDIDATES INTEGRILIN ® MLN2222 INTEGRILIN ® (EPTIFIBATIDE) INJECTION Millennium is investigating the potential role of INTEGRILIN beyond its currently approved indications.INTEGRILIN is contraindicated in patients with a history of...
14040.L.qxd page 1
author: NoemiC
14040.L.qxd Complex Precision Statistics (Abciximab) as Defined by NCCLS Complex Precision Within- Run Whole Blood (Simple) Total Description n n (days) (results) Mean SD CV % SD CV % Female Age 26 20 80 188.3 9.8 5.2 18.7 9.9 Female Age 41 20 80 187.0 9.1 4.9 26.1 13.9 Male Age 29 20 80 224.8 11.1 4.9 25.9 11.5 Complex Precision Statistics (Eptifibatide) as Defined by NCCLS Complex...
author: NoemiC
http://www.fda.gov/cder/orange/appendix_a.txt ACTHAR GEL, CORTICOTROPIN H.R.-50, HYDROCHLOROTHIAZIDE HABITROL, NICOTINE (OTC) HALCION, TRIAZOLAM HALDOL SOLUTAB, HALOPERIDOL HALDOL, HALOPERIDOL HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE HALDRONE, PARAMETHASONE ACETATE HALFAN, HALOFANTRINE HYDROCHLORIDE HALOG, HALCINONIDE HALOG-E, HALCINONIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL INTENSOL,...
20-718_Integrilin (Eptifibatide) Injection Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Integrilin (Eptifibatide) Injection Company:--COR Therapeutics, Inc
author: Paul Stauffer
20718S002_Integrilin.htm Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Integrilin (Eptifibatide) Injection Company:- COR Therapeutics, Inc
author: Paul Stauffer
20-718_Integrilin Eptifibatide Injection Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Integrilin (Eptifibatide) Injection Company:--COR Therapeutics, Inc
author: Paul Stauffer
http://www.accumetrics.com/uploads/GUSTOVan.pdf Journal of Thrombosis and Thrombolysis 14( 3), 197TH 203, 2002
RLD LABELING APPROVED IN SEPTEMBER 1998 Reference Listed Drug Labeling Approved in September 1998 Some of the product names below contain links to the approved labeling or the supplemental approval letter describing the specific changes.- Click on the product name to view the approved labeling changes in Adobe Acrobat format
FDA Drug Approvals List June 2001 Catarrhalis (including B-lactamase-producing strains) Original Application #: 021224 Approval Date: 22-JUN-01 Trade Name: REMINYL Chemical Type: 3 Therapeutic Potential: S Dosage Form: SOLUTION Applicant: JANSSEN RESEARCH FDN Active Ingredient(s): GALANTAMINE HYDROBROMIDE OTC/RX Status: RX Indication(s): For the treatment of mild to moderate dementia of the Alzheimer's type Original...
Prescription and OTC Drug Product List 2/2002 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST AMOXICILLIN; CLAVULANATE POTASSIUM FOR SUSPENSION; ORAL AUGMENTIN '400' -D- + GLAXOSMITHKLINE 400MG/5ML;EQ 57MG BASE/5ML N50725 002 MAY 31, 1996 FEB CRLD -A- 400MG/5ML;EQ 57MG BASE/5ML N50725 002 MAY 31, 1996 FEB CRLD AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE TABLET; ORAL ...
http://www.fda.gov/cder/foi/label/2001/20718s13lbl.pdf Table 7 Bleeding Events and Transfusions in the PURSUIT, ESPRIT and IMPACT II Studies Placebo Eptifibatide Eptifibatide 180/ 1.3* 180/ 2.0 PURSUIT n (%) n (%) n (%) Patients 4696 1472 4679 Major bleeding a 425 (9.3%) 152 (10.5%) 498 (10.8%) Minor bleeding a 347 (7.6%) 152 (10.5%) 604 (13.1%) Requiring Transfusions b 490 (10.4%) 188 (12.8%) 601 (12.8%) Placebo ...
http://www.fda.gov/cder/foi/label/2001/20718s13lbl.pdf page 5
duplicates:http://www.millennium.com/images/INTEGRILIN(r)insert.pdf http://www.corr.com/images/INTEGRILIN(r)insert.pdf http://www.millennium.com/images/salesaid.pdf
http://www.fda.gov/cder/foi/label/2001/20718s13lbl.pdf page 4
duplicates:http://www.millennium.com/images/INTEGRILIN(r)insert.pdf http://www.corr.com/images/INTEGRILIN(r)insert.pdf http://www.millennium.com/images/salesaid.pdf
http://www.fda.gov/cder/foi/label/2001/20718s13lbl.pdf page 3
duplicates:http://www.millennium.com/images/INTEGRILIN(r)insert.pdf http://www.corr.com/images/INTEGRILIN(r)insert.pdf http://www.millennium.com/images/salesaid.pdf
http://www.fda.gov/cder/foi/label/2001/20718s13lbl.pdf page 2
http://www.fda.gov/cder/foi/label/2001/20718s13lbl.pdf page 1
INTEGRILIN? (eptifibatide) INJECTION CONFIDENTIAL Page 1 May 1, 2001 INTEGRILIN (eptifibatide) INJECTION For Intravenous Administration DESCRIPTION Eptifibatide is a cyclic heptapeptide containing six amino acids and one mercaptopropionyl (des- amino cysteinyl) residueEptifibatide ...
author: AGLENN
INTEGRILIN? (eptifibatide) INJECTION page 30
author: AGLENN
INTEGRILIN? (eptifibatide) INJECTION page 29
author: AGLENN
INTEGRILIN? (eptifibatide) INJECTION page 27
author: AGLENN
